Detection of Volatile Organic Compounds as Potential Novel Biomarkers for Chorioamnionitis - Proof of Experimental Models

Background: Histologic chorioamnionitis is only diagnosed postnatally which prevents interventions. We hypothesized that volatile organic compounds (VOCs) in the amniotic fluid might be useful biomarkers for chorioamnionitis and that VOC profiles differ between amnionitis of different origins.Method...

Full description

Saved in:
Bibliographic Details
Main Authors: Sybelle Goedicke-Fritz (Author), Thomas Werner (Author), Hendrik J. Niemarkt (Author), Tim G. A. M. Wolfs (Author), Jörg Ingo Baumbach (Author), Matthew W. Kemp (Author), Alan H. Jobe (Author), Tobias Rogosch (Author), Michelle Bous (Author), Elisabeth Kaiser (Author), Regine Stutz (Author), Sascha Meyer (Author), Rolf Felix Maier (Author), Andreas Rembert Koczulla (Author), Owen Brad Spiller (Author), Boris W. Kramer (Author), Michael Zemlin (Author)
Format: Book
Published: Frontiers Media S.A., 2021-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2b3a0176cfb44d6daae9eb85b9f9e7b2
042 |a dc 
100 1 0 |a Sybelle Goedicke-Fritz  |e author 
700 1 0 |a Sybelle Goedicke-Fritz  |e author 
700 1 0 |a Thomas Werner  |e author 
700 1 0 |a Hendrik J. Niemarkt  |e author 
700 1 0 |a Tim G. A. M. Wolfs  |e author 
700 1 0 |a Jörg Ingo Baumbach  |e author 
700 1 0 |a Matthew W. Kemp  |e author 
700 1 0 |a Alan H. Jobe  |e author 
700 1 0 |a Tobias Rogosch  |e author 
700 1 0 |a Michelle Bous  |e author 
700 1 0 |a Elisabeth Kaiser  |e author 
700 1 0 |a Regine Stutz  |e author 
700 1 0 |a Sascha Meyer  |e author 
700 1 0 |a Rolf Felix Maier  |e author 
700 1 0 |a Andreas Rembert Koczulla  |e author 
700 1 0 |a Owen Brad Spiller  |e author 
700 1 0 |a Owen Brad Spiller  |e author 
700 1 0 |a Boris W. Kramer  |e author 
700 1 0 |a Boris W. Kramer  |e author 
700 1 0 |a Michael Zemlin  |e author 
245 0 0 |a Detection of Volatile Organic Compounds as Potential Novel Biomarkers for Chorioamnionitis - Proof of Experimental Models 
260 |b Frontiers Media S.A.,   |c 2021-07-01T00:00:00Z. 
500 |a 2296-2360 
500 |a 10.3389/fped.2021.698489 
520 |a Background: Histologic chorioamnionitis is only diagnosed postnatally which prevents interventions. We hypothesized that volatile organic compounds (VOCs) in the amniotic fluid might be useful biomarkers for chorioamnionitis and that VOC profiles differ between amnionitis of different origins.Methods: Time-mated ewes received intra-amniotic injections of media or saline (controls), or live Ureaplasma parvum serovar 3 (Up) 14, 7 or 3d prior to c-section at day 124 gestational age (GA). 100 μg recombinant ovine IL-1α was instilled at 7, 3 or 1d prior to delivery. Headspace VOC profiles were measured from amniotic fluids at birth using ion mobility spectrometer coupled with multi-capillary columns.Results: 127 VOC peaks were identified. 27 VOCs differed between samples from controls and Up- or IL-1α induced amnionitis. The best discrimination between amnionitis by Up vs. IL-1α was reached by 2-methylpentane, with a sensitivity/specificity of 96/95% and a positive predictive value/negative predictive values of 96 and 95%. The concentration of 2-methylpentane in VOCs peaked 7d after intra-amniotic instillation of Up.Discussion: We established a novel method to study headspace VOC profiles of amniotic fluids. VOC profiles may be a useful tool to detect and to assess the duration of amnionitis induced by Up. 2-methylpentane was previously described in the exhalate of women with pre-eclampsia and might be a volatile biomarker for amnionitis. Amniotic fluids analyzed by ion mobility spectrometry coupled with multi-capillary columns may provide bedside diagnosis of amnionitis and understanding inflammatory mechanisms during pregnancy. 
546 |a EN 
690 |a antenatal inflammation 
690 |a infection 
690 |a ureaplasma 
690 |a detection 
690 |a duration 
690 |a volatile organic compounds 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pediatrics, Vol 9 (2021) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fped.2021.698489/full 
787 0 |n https://doaj.org/toc/2296-2360 
856 4 1 |u https://doaj.org/article/2b3a0176cfb44d6daae9eb85b9f9e7b2  |z Connect to this object online.